Stableford Capital II’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-15,477
| Closed | -$1.2M | – | 121 |
|
|
2024
Q4 | $1.2M | Buy |
15,477
+10,874
| +236% | +$846K | 0.48% | 55 |
|
|
2024
Q3 | $319K | Buy |
4,603
+11
| +0.2% | +$761 | 0.13% | 119 |
|
|
2024
Q2 | $526K | Buy |
4,592
+212
| +5% | +$24.3K | 0.21% | 113 |
|
|
2024
Q1 | $608K | Buy |
4,380
+13
| +0.3% | +$1.8K | 0.24% | 101 |
|
|
2023
Q4 | $563K | Buy |
4,367
+88
| +2% | +$11.3K | 0.24% | 95 |
|
|
2023
Q3 | $347K | Buy |
4,279
+1
| +0% | +$81 | 0.16% | 96 |
|
|
2023
Q2 | $485K | Buy |
+4,278
| New | +$485K | 0.21% | 88 |
|
|
2023
Q1 | – | Sell |
-4,052
| Closed | -$446K | – | 92 |
|
|
2022
Q4 | $446K | Buy |
+4,052
| New | +$446K | 0.24% | 89 |
|